ADMIRE-CD

December 20, 2017

Alofisel for Crohn’s Fistulas Receives EMA Recommendation for Marketing Authorization in EU

News

TiGenix received a European Medicines Agency (EMA) recommendation for the marketing authorization of Alofisel (darvadstrocel, Cx601) as an advanced therapy medicinal product (ATMP) for the treatment of complex perianal fistulas in people with ... Read more

May 5, 2017May 5, 2017

Most Crohn’s Fistulas Are Still Gone a Year After Cx601 Treatment, Trial Shows

News

TiGenix’s Cx601 was able to resolve a painful Crohn’s disease condition known as complex perianal fistulas for a year, according to a Phase 3 trial. Only a quarter of the patients ... Read more

April 7, 2017May 4, 2017

Perianal Fistulas in Crohn’s Patients Effectively Treated in Long Term with Cx601, Study Finds

News

TiGenix’s lead compound Cx601 is a safe and effective long-term treatment of complex perianal fistulas in Crohn’s disease patients, a clinical trial reports. The positive results come from the 104-week extension ... Read more